U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT07469072) titled 'Comparison of Anticoagulant Effects of Different Doses of Nafamostat in Continuous Renal R... Read More
U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT07471516) titled 'Zoledronic Acid Treatment in Patients With Congenital Dyserythropoietic Anemia' on March 0... Read More
U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT07469150) titled 'Efficacy of Different Disinfection Technologies in Molar Non-Surgical Retreatment' on Marc... Read More
U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT07471841) titled 'Olutasidenib in Relapsed IDH1 Mutated AML Patients Who Have Previously Received Venetoclax... Read More
U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT07469488) titled 'A Clinical Trial on the Outcomes of Comprehensive Enhanced Prophylaxis Management (CEPM) i... Read More
U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT07468903) titled 'Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer' on March... Read More
U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT07471477) titled 'Whole Mouth Bacterial Reduction for a Manual Toothbrush With a 360-Degree Mouth Cleaner De... Read More
U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT07471438) titled 'Study of Concordance Between Inflammatory Activity Assessed by Enteric MRI With and Withou... Read More
U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT07471009) titled 'Development of Patient Derived Xenografts (PDXs) and Analysis of Tyrosine Kinase Receptor ... Read More
U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT07470489) titled 'A Multi-Center Single-Arm Phase 2 Trial Of Zanzalintinib In Combination With Cemiplimab In... Read More